Cencora, INC. (COR) — 10-K Filings
All 10-K filings from Cencora, INC.. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
Cencora Eyes 8.4% Pharma Growth, Boosts Generics & Global Reach
— Nov 25, 2025 Risk: medium
Cencora, Inc. (COR) filed its 10-K for the fiscal year ended September 30, 2025, highlighting its position as a major global pharmaceutical sourcing and distrib -
Cencora, Inc. Files 2024 10-K Report
— Nov 26, 2024 Risk: medium
Cencora, Inc. (formerly AmerisourceBergen Corp) filed its 2024 10-K report for the fiscal year ending September 30, 2024. The company, a wholesale distributor o
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX